title: Pediatric Asthma--do we need more innovation for treatment?
authors.affiliation: Children's Hospital Schwarzach, Schwarzach, Austria. josef.riedler@kh-schwarzach.at.
authors.forename: Josef
authors.initials: J
authors.lastname: Riedler
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001249:Asthma / Q000276:immunology / Q000628:therapy*; D002648:Child; D016207:Cytokines / Q000276:immunology; D003888:Desensitization, Immunologic / Q000379:methods / Q000639:trends; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D000069444:Omalizumab; D010372:Pediatrics; D035703:Therapies, Investigational
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D016207:Cytokines; D020024:Leukotriene Antagonists; D000069444:Omalizumab; D007073:Immunoglobulin E